top of page


Learn about our team's ongoing projects.

URBAN ARCH logo of the globe

The ARCH ADEPTT trial studies tuberculosis preventative therapy (IPT) in HIV+ adults in Uganda who drink heavily. The study is meant to evaluate the risks and benefits of IPT within this population. A simulation model component will use results from the trial to simulate out effects at a population level.



The Syndemics Team is composed of national leaders in infectious disease research. Our team routinely produces editorials and commentaries on recent and significant research in the field.

Editorials and Commentaries

bottom of page